home / stock / sght / sght news

SGHT News and Press, Sight Sciences Inc. From 09/12/23

Stock Information
Company Name: Sight Sciences Inc.
Stock Symbol: SGHT
Market: NASDAQ
Website: sightsciences.com
Menu
SGHT SGHT Quote SGHT Short SGHT News SGHT Articles SGHT Message Board
Get SGHT Alerts

News, Short Squeeze, Breakout and More Instantly...
SGHT - Investigation of Sight Sciences, Inc. (SGHT) Announced by Holzer & Holzer, LLC

ATLANTA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Sight Sciences, Inc. (“Sight Sciences” or “the Company”) (NASDAQ: SGHT) complied with federal securities laws. On September 11, 2023, Sight Sciences announced its third quarte...
SGHT - CGC, BLRX and WHLR among pre-market losers

2023-09-12 08:42:44 ET Losers: Acelyrin ( SLRN ) -56% announces top-line results from placebo-controlled clinical trial of Izokibep for moderate-to-severe Hidradenitis Suppurativa. Sight Sciences ( SGHT ) -31% on updated guidance . Super League Gaming (...

SGHT - Biggest stock movers today: WestRock, Oracle and more

2023-09-12 06:14:55 ET Related stories Compare metrics for HUMA to ORCL, SGHT, SLRN, WRK WestRock: Solid Asset-Based, But (Likely) Not The Right Time Reevaluating Acelyrin: The Impact Of Mixed Izokibep Results (Rating Downgrade) Oracle Corporation ( ORCL ...

SGHT - Sight Sciences down 28% on updated guidance

2023-09-12 06:08:49 ET More on Sight Sciences Sight Sciences: Staying Bullish After Q2 Results Beat Sight Sciences cut to Neutral at Citi on reimbursement uncertainty For further details see: Sight Sciences down 28% on updated guidance
SGHT - ADMA, ALLK and NRIX are among after hour movers

2023-09-11 17:20:07 ET Gainers: Matrix Service  ( MTRX ) +10% . Adeia  ( ADEA ) +7% . Allakos  ( ALLK ) +5% . Nurix Therapeutics ( NRIX ) +5% . ADMA Biologics ( ADMA ) +4% . Losers: ACELYRIN ( SLRN ) ...

SGHT - Sight Sciences Provides Revenue Guidance for the Third Quarter of 2023 and Updates Revenue Guidance for Full Year 2023

MENLO PARK, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patient...

SGHT - Sight Sciences Appoints Matt Link as Chief Commercial Officer

MENLO PARK, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patient...
SGHT - Sight Sciences to Present at the Upcoming Morgan Stanley 21st Annual Global Healthcare Conference

MENLO PARK, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients...

SGHT - Sight Sciences: Staying Bullish After Q2 Results Beat

2023-08-07 14:00:05 ET Summary Sight Sciences' Q2 2023 financial performance came in above Wall Street analysts, and SGHT's stock price rose by +7.6% last Friday following its results announcement. SGHT's key markets, glaucoma and dry eye, have addressable markets worth billions o...

SGHT - Sight Sciences, Inc. (SGHT) Q2 2023 Earnings Call Transcript

2023-08-06 07:32:09 ET Sight Sciences, Inc. (SGHT) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Philip Tailor - Investor Relations Paul Badawi - Co-Founder & Chief Executive Officer Ali Bauerlein - Chief Financial Officer ...
Previous 10 Next 10